Sequential determination of pharmacokinetics (PK) and pharmacodynamics (PD) of mycophenolate mofetil (MMF) in liver transplant (LT) patients.

被引：0
|
作者：
Brunet, M
Martorell, J
Vidal, E
Jimenez, O
Millan, O
Rojo, I
Cirera, I
Rimola, A
机构：
[1] Hosp Clin Barcelona, IDIBAPS, Liver Unit, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, IDIBAPS, Dept Toxicol, E-08036 Barcelona, Spain
[3] Hosp Clin Barcelona, IDIBAPS, Dept Immunol, E-08036 Barcelona, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1351
引用
收藏
页码：528 / 529
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics (PK) of intravenous mycophenolate mofetil (MMF) in liver transplant patients.
    Hebert, MF
    Chang, T
    Linna, TJ
    Hale, MD
    Roberts, JP
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI101 - PI101
  • [2] Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil
    Brunet, M
    Cirera, I
    Martorell, J
    Vidal, E
    Millán, O
    Jiménez, O
    Rojo, I
    Londoño, MC
    Rimola, A
    [J]. TRANSPLANTATION, 2006, 81 (04) : 541 - 546
  • [3] Pharmacokinetics (PK) and pharmacodynamics (PD) of mycophenolic acid (MPA) in stable renal transplant recipients treated with suboptimal doses of mycophenolate mofetil (MMF)
    Brunet, M
    Martorell, J
    Oppenheimer, F
    Vilardell, J
    Millán, O
    Carrillo, M
    Corbella, J
    [J]. TRANSPLANTATION, 1999, 67 (07) : S205 - S205
  • [4] PHARMACOKINETICS (PK) OF ORAL MYCOPHENOLATE MOFETIL (MM) IN LIVER-TRANSPLANT PATIENTS
    HEBERT, MF
    BENET, LZ
    GOMEZ, D
    LEE, R
    LINNA, TJ
    SHAH, J
    ROBERTS, JP
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 164 - 164
  • [5] Pharmacokinetics of Mycophenolate Mofetil in Pediatric Liver Transplant Recipients to Optimize MMF Dose
    Barau, C.
    Habes, D.
    Debray, D.
    Taburet, A. M.
    Furlan, V.
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 651 - 652
  • [6] Use of Mycophenolate Mofetil in Liver Transplant Patients.
    Bravo, Gomez M. A.
    Barrera, L.
    Jimenez, M.
    Rodrigo, J.
    Marin, D.
    De la Mata, M.
    Garcia, Nunez F.
    Garrido, Lopez M. A.
    Noguera, F.
    Vivaldi, Martin R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 531 - 532
  • [7] Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients
    Militano, O.
    Hedgpeth, D.
    Shaw, L. M.
    Figurski, M.
    Satwani, P.
    Ayello, J.
    Roman, E.
    Bradley, B.
    George, D.
    Garvn, J.
    Bhatia, M.
    Wolownick, K.
    Foley, S.
    Hawkes, R.
    Cairo, M. S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 114 - 115
  • [8] Pharmacokinetics and pharmacodynamics (PK/PD) of terazosin in hypertensive patients.
    Granneman, R
    Achari, R
    Hosmane, B
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII60 - PII60
  • [9] Measurement of circulatory unhydrolysed mycophenolate mofetil (MMF) to mycophenolic acid (MPA) with intravenous MMF in post liver transplant patients.
    Jain, Ashok
    Mohanka, Ravi
    Tai, Kwong
    Orloff, Mark
    Abt, Peter
    Bozorgzadeh, Adel
    [J]. LIVER TRANSPLANTATION, 2006, 12 (05) : C125 - C125
  • [10] Mycophenolate mofetil (MMF) in pediatric liver transplant recipients
    Dhawan, A
    Lewis, PN
    Heaton, ND
    Baker, AJ
    Rela, M
    Hadzic, N
    Srinivasan, P
    MieliVergani, G
    [J]. HEPATOLOGY, 1997, 26 (04) : 1487 - 1487
12345